These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Leflunomide: friend or foe for systemic lupus erythematosus?
    Author: Wu GC, Xu XD, Huang Q, Wu H.
    Journal: Rheumatol Int; 2013 Feb; 33(2):273-6. PubMed ID: 22961090.
    Abstract:
    Leflunomide is a new immunosuppressive medicine that has been effectively used in the therapy of rheumatoid arthritis and subsequently used with success in animal models and patients with systemic lupus erythematosus (SLE). However, its use has also been associated with significant and serious adverse reactions involving hematological, hepatic, immune, dermatological and respiratory systems. In the current review, we attempt to describe the two sides of this drug in the treatment of SLE.
    [Abstract] [Full Text] [Related] [New Search]